Teva Pharmaceutical Q2 2022 Earnings Results

Teva Pharmaceutical Industries presents Q2 2022 financial results and provides a strategy update with 2027 long-term financial targets. The presentation discusses generic and specialty pharmaceutical business performance, including branded products such as AUSTEDO, AJOVY, and COPAXONE, alongside updates on opioid litigation matters.